Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primidone for amyotrophic lateral sclerosis
ChiCTR2100051651Phase 2Not yet recruiting
- Sponsor
- Yichang First People's Hospital
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of primidone in amyotrophic lateral sclerosis (ALS), sponsored by Yichang First People's Hospital. Primary endpoints: Modified ALS Functional Score, ROADS scale and 2 more. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
primidone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on ChiCTR2100051651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051651.